Evidence map›Paper›PMID 23837993›Full record

ArticleJournal of the American Medical Informatics Association : JAMIA2013

A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injury.

Casey Lynnette Overby, Jyotishman Pathak, Omri Gottesman, Krystl Haerian, Adler Perotte, Sean Murphy, Kevin Bruce, Stephanie Johnson, Jayant Talwalkar, Yufeng Shen and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Medical Informatics Association : JAMIA, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The Effectiveness of Multitask Learning for Phenotyping with Electronic Health Records Data.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2019
    Article
  15. High-fidelity phenotyping: richness and freedom from bias.Journal of the American Medical Informatics Association : JAMIA · 2018
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Automated identification of an aspirin-exacerbated respiratory disease cohort.The Journal of allergy and clinical immunology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Casey Lynnette OverbyDepartment of Biomedical Informatics, Columbia University, New York, New York, USA.
Jyotishman Pathak
Omri Gottesman
Krystl Haerian
Adler Perotte
Sean Murphy
Kevin Bruce
Stephanie Johnson
Jayant Talwalkar
Yufeng Shen
Steve Ellis
Iftikhar Kullo
Christopher Chute
Carol Friedman
Erwin Bottinger
George Hripcsak
Chunhua Weng
Columbia University · USMayo Clinic in Florida · USIcahn School of Medicine at Mount Sinai · USMayo Clinic · USUniversity of Maryland, Baltimore · US

Funding

Training in Biomedical Informatics at Columbia UniversityT15LM007079 · NLM · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI NOEMIE ELHADAD, GEORGE M HRIPCSAK · 1992 to 2026
$28.9M
Clinical and Translational Science AwardUL1TR000040 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2012 to 2015
$26.2M
Genomic Basis of Susceptibility to COVID-19 Infection and its ComplicationsU01HG006379 · NHGRI · MAYO CLINIC ROCHESTER · PI Richard R. Sharp · 2011 to 2026
$16.5M
DISCOVERING AND APPLYING KNOWLEDGE IN CLINICAL DATABASESR01LM006910 · NLM · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HRIPCSAK, GEORGE M · 2000 to 2023
$10.6M
National Infrastructure for Standardized and Portable EHR Phenotyping AlgorithmsR01GM105688 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI LUO, YUAN, PATHAK, JYOTISHMAN · 2013 to 2020
$5.7M
Bridging the Semantic Gap Between Research Eligibility Criteria and Clinical DataR01LM009886 · NLM · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WENG, CHUNHUA · 2009 to 2020
$5.3M
Biorepository for Genomic Medicine in diverse CommunitiesU01HG006380 · NHGRI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BOTTINGER, ERWIN P. · 2011 to 2015
$4.5M
Pharmacovigilence using Natural Language Processing, Statistics, and the EHRR01LM010016 · NLM · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FRIEDMAN, CAROL · 2009 to 2016
$3.4M
Uppper Midwest Drug Hepatoxicity ConsortiumU01DK082992 · NIDDK · MAYO CLINIC ROCHESTER · PI TALWALKAR, JAYANT A · 2008 to 2012
$1.1M
NCATS NIH HHS UL1 TR000040NHGRI NIH HHS U01 HG006379NHGRI NIH HHS U01 HG006380NIDDK NIH HHS U01 DK082992NIGMS NIH HHS R01 GM105688NLM NIH HHS R01 LM006910NLM NIH HHS R01 LM009886NLM NIH HHS R01 LM010016NLM NIH HHS T15 LM007079
6 · The paper itself

Abstract

objectiveTo describe a collaborative approach for developing an electronic health record (EHR) phenotyping algorithm for drug-induced liver injury (DILI).

methodsWe analyzed types and causes of differences in DILI case definitions provided by two institutions-Columbia University and Mayo Clinic; harmonized two EHR phenotyping algorithms; and assessed the performance, measured by sensitivity, specificity, positive predictive value, and negative predictive value, of the resulting algorithm at three institutions except that sensitivity was measured only at Columbia University.

resultsAlthough these sites had the same case definition, their phenotyping methods differed by selection of liver injury diagnoses, inclusion of drugs cited in DILI cases, laboratory tests assessed, laboratory thresholds for liver injury, exclusion criteria, and approaches to validating phenotypes. We reached consensus on a DILI phenotyping algorithm and implemented it at three institutions. The algorithm was adapted locally to account for differences in populations and data access. Implementations collectively yielded 117 algorithm-selected cases and 23 confirmed true positive cases. DISCUSSION: Phenotyping for rare conditions benefits significantly from pooling data across institutions. Despite the heterogeneity of EHRs and varied algorithm implementations, we demonstrated the portability of this algorithm across three institutions. The performance of this algorithm for identifying DILI was comparable with other computerized approaches to identify adverse drug events.

conclusionsPhenotyping algorithms developed for rare and complex conditions are likely to require adaptive implementation at multiple institutions. Better approaches are also needed to share algorithms. Early agreement on goals, data sources, and validation methods may improve the portability of the algorithms.

Indexed as

AlgorithmsElectronic Health RecordsPhenotypeChemical and Drug Induced Liver InjuryHumansDrug-induced liver injuryElectronic health recordsPharmacovigilancePhenotypingRare diseases

Identifiers

PMID23837993
PMCPMC3861914
OpenAlexW2160913515

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.